ConductScience.org, home

Paper93544

Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.

Thulesius O and 2 others. Eur J Clin Pharmacol, 1979. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins. Papers, record 93544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/93544

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
2.62
iCite
Revised in PubMed
2019-12-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thulesius OO
2Gjöres JEJ E
3Berlin EE

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DihydroergotamineMajor topic
EthanolaminesMajor topic
EtilefrineMajor topic
MidodrineMajor topic
NorepinephrineMajor topic
PhenylephrineMajor topic
Vasoconstrictor AgentsMajor topic
Humans
In Vitro Techniques
Muscle, Smooth, Vascular
Veins

Source PubMed

Download CSV of topics

References5

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14600383[The pharmacological properties of Midodrin and its clinical application in patients with hypotensive circulatory disturbance (author's transl)].Wien Klin Wochenschr1974https://conductscience.org/library/papers/4600383PubMed
256818[Treatment of hypotensive circular dysregulation using Gutron in practice].Wien Med Wochenschr1975https://conductscience.org/library/papers/56818PubMed
3788906Pathophysiological classification and diagnosis of orthostatic hypotension.Cardiology1976https://conductscience.org/library/papers/788906PubMed
466056Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite, ST 1059.Arzneimittelforschung1976https://conductscience.org/library/papers/66056PubMed
5684381Physiological and pharmacological studies on isolated human bronchial preparations.Scand J Respir Dis1978https://conductscience.org/library/papers/684381PubMed

Download CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
39944289Use of Midodrine for Intraoperative Hemostasis in Cutaneous and Percutaneous Surgery.JID Innov2025https://conductscience.org/library/papers/39944289PubMed
39102112
Facile Integration of Hanztsch's Switch-Off/On Modeled Fluorogenic Probe for Feasible Tagging and Tracking of the Midodrine Drug in Different Matrices; First Evaluation of the Method's Greenness, Whiteness, Blueness, Quantum Yield, and Tablets' Content Homogeneity.
J Fluoresc2025https://conductscience.org/library/papers/39102112PubMed
38047013Midodrine use in critically ill patients: a narrative review.Crit Care Resusc2022https://conductscience.org/library/papers/38047013PubMed
28011746The Pharmacology of Autonomic Failure: From Hypotension to Hypertension.Pharmacol Rev2017https://conductscience.org/library/papers/28011746PubMed
27271310Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine.Hypertension2016https://conductscience.org/library/papers/27271310PubMed
27169082Effect of Alpha-1-Adrenergic Agonist, Midodrine for the Management of Long-Standing Neurogenic Shock in Patient with Cervical Spinal Cord Injury: A Case Report.Korean J Neurotrauma2015https://conductscience.org/library/papers/27169082PubMed
9467688Midodrine. A review of its therapeutic use in the management of orthostatic hypotension.Drugs Aging1998https://conductscience.org/library/papers/9467688PubMed
6489409Pharmacological actions of the main metabolites of dihydroergotamine.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6489409PubMed
6096723Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.Naunyn Schmiedebergs Arch Pharmacol1984https://conductscience.org/library/papers/6096723PubMed
2480881Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders.Drugs1989https://conductscience.org/library/papers/2480881PubMed
1712258Idiopathic orthostatic hypotension, midodrine, and anaesthesia.Can J Anaesth1991https://conductscience.org/library/papers/1712258PubMed
1349888Pharmacological analysis of positive chronotropic and inotropic responses to etilefrine in isolated dog heart preparations.Heart Vessels1992https://conductscience.org/library/papers/1349888PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/93544

GET https://conductscience.org/api/papers/v1/93544/authors